⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3225027 | 1.00 | — | — | |
| SCHEMBL3232584 | 1.00 | — | — | |
| SCHEMBL38654566 | 1.00 | — | — | |
| SCHEMBL10384525 | 0.97 | HTR6 (0.52) | — | |
| SCHEMBL6194042 | 0.97 | HTR6 (0.52) | — | |
| SCHEMBL583879 | 0.97 | HTR6 (0.56) | — | |
| SCHEMBL127850 | 0.97 | HTR6 (0.56) | — | |
| SCHEMBL24782761 | 0.93 | HTR6 (0.54) | — | |
| SCHEMBL22216666 | 0.93 | HTR6 (0.54) | — | |
| SCHEMBL21057351 | 0.93 | HTR6 (0.54) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 581 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260048156-A1 | FAP-TARGETING PHARMACEUTICAL PRODUCT FOR THERAPY AND DIAGNOSIS OF CANCERS | Atoms for Cure GmbH (DE) | 2026-02-19 | — | — | US | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| EP-4486395-A1 | PRECURSOR MARKERS AND RADIOTRACERS WITH THREE OR MORE TARGETING VECTORS FOR THERANOSTICS USED IN NUCLEAR MEDICINE | Atoms for Cure GmbH (DE) | 2025-01-08 | — | — | EP | claimed |
| CN-119060047-A | Fluoro polyhydroxy indolizidine compound, pharmaceutically acceptable salt thereof, synthesis method, glycosidase inhibitor and application | 中国科学院化学研究所 | 2024-12-03 | — | — | CN | claimed |
| EP-4452326-A1 | FAP-TARGETING PHARMACEUTICAL PRODUCT FOR THERAPY AND DIAGNOSIS OF CANCERS | Atoms for Cure GmbH (DE) | 2024-10-30 | — | — | EP | claimed |
| CN-118791480-A | Heteroaromatic ring compounds and application thereof | 上海艾力斯医药科技股份有限公司 | 2024-10-18 | — | — | CN | claimed |
| CN-118785925-A | Marker precursors and radiotracers with three or more targeting vectors for use in diagnostic nuclear medicine therapies | 原子治疗有限公司 | 2024-10-15 | — | — | CN | claimed |
| CN-112204016-B | Process for preparing fungicidally active triazole compounds | UPL有限公司 | 2024-06-21 | — | — | CN | claimed |
| US-20240092815-A1 | ORGANOMETALLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-03-21 | — | — | US | claimed |
| WO-2023165987-A1 | PRECURSOR MARKERS AND RADIOTRACERS WITH THREE OR MORE TARGETING VECTORS FOR THERANOSTICS USED IN NUCLEAR MEDICINE | Atoms for Cure GmbH (DE) | 2023-09-07 | — | — | WO | claimed |
| WO-1999065906-A1 | BICYCLIC PIPERIDINE AND PIPERAZINE COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY | ALLELIX BIOPHARMACEUTICALS INC. (CA) | 1999-12-23 | — | — | WO | claimed |
| CN-1065066-A | The preparation method of castano spermine glycosides | MERRELL DOW PHARMA (US) | 1992-10-07 | — | — | CN | claimed |
| EP-0237169-B1 | 5-SUBSTITUTED OCTAHYDROINDOLIZINE ANALGESICS COMPOUNDS AND 7-KETO INTERMEDIATES | McNeilab, Inc. (US) | 1992-07-08 | — | — | EP | claimed |
| EP-0187711-B1 | OCTAHYDROINDOLIZINE COMPOUNDS USEFUL AS ANALGESICS | McNeilab, Inc. (US) | 1990-08-29 | — | — | EP | claimed |
| EP-0241298-A2 | 3-diphenyl substituted octahydroindolizine analgesic compounds | McNeilab, Inc. (US) | 1987-10-14 | — | — | EP | claimed |
| EP-0237169-A1 | 5-Substituted octahydroindolizine analgesics compounds and 7-keto intermediates | McNeilab, Inc. (US) | 1987-09-16 | — | — | EP | claimed |
| US-4689329-A | 5-substituted octahydroindolizine analgesics compounds and 7-keto intermediates | MCNEILAB, INC. (US) | 1987-08-25 | — | — | US | claimed |
| US-4683239-A | 3-diphenyl substituted octahydroindolizine analgesic compounds | MCNEILAB, INC. (US) | 1987-07-28 | — | — | US | claimed |
| EP-0187711-A2 | Octahydroindolizine compounds useful as analgesics | McNeilab, Inc. (US) | 1986-07-16 | — | — | EP | claimed |
| US-4582836-A | Octahydroindolizine compounds useful as analgesics | MCNEILAB, INC. (US) | 1986-04-15 | — | — | US | claimed |